123 related articles for article (PubMed ID: 30519267)
1. Curative Anti-Inflammatory Properties of Chinese Optimized Yinxieling Formula in Models of Parkinson's Disease.
Wei R; OuYang J; Lin W; Lin T
Evid Based Complement Alternat Med; 2018; 2018():6142065. PubMed ID: 30519267
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson's Disease through the Inflammation Pathway.
Wei R; Rong C; Xie Q; Wu S; Feng Y; Wang R; Dai Z; Lin T
Evid Based Complement Alternat Med; 2019; 2019():2529641. PubMed ID: 31929812
[TBL] [Abstract][Full Text] [Related]
3. Anti-psoriasis molecular targets and active components discovery of Optimized Yinxieling Formula via affinity-purified strategy.
Wang W; Liu L; Yang Z; Lu C; Tu P; Zhao R; Zeng K
Chin J Nat Med; 2024 Feb; 22(2):127-136. PubMed ID: 38342565
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
5. Bushen-Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson's Disease.
Mo Y; Xu E; Wei R; Le B; Song L; Li D; Chen Y; Ji X; Fang S; Shen J; Yang C; Wang Q
Evid Based Complement Alternat Med; 2018; 2018():3571604. PubMed ID: 30224927
[TBL] [Abstract][Full Text] [Related]
6. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
7. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
[TBL] [Abstract][Full Text] [Related]
8. Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways.
Lee Y; Chun HJ; Lee KM; Jung YS; Lee J
Brain Res; 2015 Nov; 1627():233-42. PubMed ID: 26434409
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
[TBL] [Abstract][Full Text] [Related]
11. CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease.
Chung YC; Shin WH; Baek JY; Cho EJ; Baik HH; Kim SR; Won SY; Jin BK
Exp Mol Med; 2016 Jan; 48(1):e205. PubMed ID: 27534533
[TBL] [Abstract][Full Text] [Related]
12. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice.
Manocha GD; Floden AM; Puig KL; Nagamoto-Combs K; Scherzer CR; Combs CK
Mol Neurodegener; 2017 Feb; 12(1):17. PubMed ID: 28196514
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q
Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
[TBL] [Abstract][Full Text] [Related]
15. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice.
Jang Y; Koo JH; Kwon I; Kang EB; Um HS; Soya H; Lee Y; Cho JY
Brain Res; 2017 Jan; 1655():186-193. PubMed ID: 27816415
[TBL] [Abstract][Full Text] [Related]
17. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
18. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
Yang J; Jia M; Zhang X; Wang P
Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
[TBL] [Abstract][Full Text] [Related]
19. Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner.
Zhang B; Wang G; He J; Yang Q; Li D; Li J; Zhang F
J Neuroinflammation; 2019 Apr; 16(1):92. PubMed ID: 31010422
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease.
Kim ME; Lee JY; Lee KM; Park HR; Lee E; Lee Y; Lee JS; Lee J
Arch Pharm Res; 2016 Aug; 39(8):1160-70. PubMed ID: 27469335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
